Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

Fig. 2

To compare Kaplan-Meier curves for time-to-progression analysis, the patient cohort treated with standard PD1 inhibitor therapy was stratified by absolute lymphocyte count (ALC) of 600 cells/μl as described in the methods section. Patients with ALC < 600 cells/μl were associated with significantly shorter PFS. *P < 0.05 by Wilcoxon test

Back to article page